Show simple item record

dc.contributor.authorIcli, A; Aksoy, F; Dogan, A; Arslan, A; Akcay, S; Yucel, H; Ersoy, I; Gorgulu, O
dc.date.accessioned2020-07-01T08:35:54Z
dc.date.available2020-07-01T08:35:54Z
dc.date.issuedMAY
dc.date.issued2014
dc.identifier.urihttp://hdl.handle.net/20.500.12481/6988
dc.description.abstractThromboembolic events may be seen in patients with hypertrophic cardiomyopathy (HCM). We investigated the mean platelet volume (MPV), an indicator of platelet activation in patients with HCM. This study included 112 patients with HCM, in which 40 were patients with hypertrophic obstructive cardiomyopathy (HOCM), and 106 were control participants. The MPV was significantly higher in patients with HCM than in controls (9.1 +/- 0.3 vs 7.9 +/- 0.3 fL, P = .01). In the subgroup analyses, MPV was also higher in patients with HOCM compared to those with hypertrophic nonobstructive cardiomyopathy (HNCM; 9.3 +/- 0.3 vs 9.0 +/- 0.2 fL, P = .01). Similarly, patients with HNCM had higher MPV values than controls (9.0 +/- 0.2 vs 7.9 +/- 0.3 fL, P = .01). The MPV was significantly and positively correlated with left ventricular outflow tract (LVOT) obstruction (r = .42, P = .001) and septal thickness (r =.62, P = .001). In linear regression analysis, MPV was independently associated only with septal thickness (beta = .07, 95% confidence interval: 0.04-0.09, P = .001). The MPV can be elevated in patients with HCM regardless of the obstruction of LVOT and may be associated with the severity of septal thickness.
dc.titleIncreased Mean Platelet Volume in Hypertrophic Cardiomyopathy
dc.title.alternativeANGIOLOGY
dc.identifier.DOI-ID10.1177/0003319713483919
dc.identifier.volume65
dc.identifier.issue5
dc.identifier.startpage420
dc.identifier.endpage424
dc.identifier.issn/e-issn0003-3197
dc.identifier.issn/e-issn1940-1574


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record